The new Phase 2 clinical trial protocol focuses on a specific patient population (advanced, recurrent, platinum-resistant ovarian cancer patients) with limited treatment options, highlighting the ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

Anixa Biosciences (ANIX) announced that it, along with its partner Moffitt Cancer Center, has received approval for an amendment to the ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Now such calls to make clinical trial data transparent – along with openly accessible protocols, papers, and summary results – are really burgeoning, and it’s easy to lose the plot.

Clinical trials can assist you in getting the right treatment for your condition. Before you consider it, here's what you ...

Q3 2025 Management View CEO Jim Frakes noted that Aethlon Medical has made significant progress in focusing on oncology and implementing cost reductions. Operating expenses were reduced by 50% ...

In this video interview, Dominique Demolle, CEO of Cognivia, highlights how patient non-adherence could increase trial ...

One patient with TNBC describes the challenges she faced trying to de-escalate a grueling treatment regimen despite warnings ...

Yunu manages more than 5,000 active clinical trial protocols and serves as the primary source of imaging endpoint data for over 25% of all NCI-designated cancer centers. The partnership between Yunu ...

The U.S. Food and Drug Administration (FDA), and the Office of Human Research protections (OHRP) released draft guidance titled, “Considerations ...